DrugBank ID: db00704
Synonymous :17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one | 17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one | n-cyclopropylmethyl-14-hydroxydihydromorphinone | n-cyclopropylmethylnoroxymorphone | naltrexon | naltrexona | naltrexone | naltrexonum
Drug Sentece Context
Table 1. Analysis of context sentence of naltrexone gene in 1 abstracts.
|32930058||Herein, we report that the FDA-approved non-peptide opioid antagonist drug, naltrexone suppresses high fat/LPS induced pro-inflammatory cytokine release both from macrophage cells and Adipose Tissue Macrophage. […] Moreover, Low Dose Naltrexone (LDN) also showed its activity as an ERK1/2 inhibitor. […] Clinical toxicity measurements may not be required for LDN since naltrexone was previously tested and is an approved drug by the FDA.|